Serrano-García B, Bartrina-Rodríguez I, Zubeldia-Varela JM, Cebrián-Carretero JL, del-Castillo-Pardo-de-Vera JL, Pardo-Montero J, et al. Preliminary study of the Craniofacial Pain and Disability Inventory-11: validation for patients with head and neck cancer. Med Oral Patol Oral Cir Bucal. 2021 Sep 1;26 (5):e661-8.



doi:10.4317/medoral. 24673

https://dx.doi.org/doi:10.4317/medoral.24673


1. Argiris A, Karamouzis MV, Raben D, Ferris RL. Head and neck cancer. Lancet. 2008;371:1695-709.

https://doi.org/10.1016/S0140-6736(08)60728-X

PMid:18486742

2. Gillison ML, Chaturvedi AK, Anderson WF, Fakhry C. Epidemiology of Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma. J Clin Oncol. 2015;33:3235-42.

https://doi.org/10.1200/JCO.2015.61.6995

PMid:26351338 PMCid:PMC4979086

3. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359-86.

https://doi.org/10.1002/ijc.29210

PMid:25220842 

4. Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011;29:4294-301.

https://doi.org/10.1200/JCO.2011.36.4596

PMid:21969503 PMCid:PMC3221528

5. Dios PD, Lestón JS. Oral cancer pain. Oral Oncol. 2010;46:448-51.

https://doi.org/10.1016/j.oraloncology.2010.02.017

PMid:20308009 

6. Ostrom QT, Gittleman H, Liao P, Rouse C, Chen Y, Dowling J, et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. Neuro Oncol. 2014;16:iv1-63.

https://doi.org/10.1093/neuonc/nou223

PMid:25304271 PMCid:PMC4193675

7. Gorsky M, Epstein JB, Oakley C, Le ND, Hay J, Stevenson-Moore P. Carcinoma of the tongue: a case series analysis of clinical presentation, risk factors, staging, and outcome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004;98:546-52.

https://doi.org/10.1016/j.tripleo.2003.12.041

PMid:15529126 

8. Epstein J, Elad S, Eliav E, Jurevic R, Benoliel R. Orofacial pain in cancer: part II-clinical perspectives and management. J Dent Res. 2007;86:506-18.

https://doi.org/10.1177/154405910708600605

PMid:17525349 

9. Simard S, Thewes B, Humphris G, Dixon M, Hayden C, Mireskandari S, et al. Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies. J Cancer Surviv. 2013;7:300-22.

https://doi.org/10.1007/s11764-013-0272-z

PMid:23475398 

10. Quartana PJ, Campbell CM, Edwards RR. Pain catastrophizing: a critical review. Expert Rev Neurother. 2009;9:745-58.

https://doi.org/10.1586/ern.09.34

PMid:19402782 PMCid:PMC2696024

11. Madrid A, Carlos RJ, La Touche R, de Estudios CS, La Salle U, la Salle C. Craniofacial pain and disability inventory (CF-PDI): development and psychometric validation of a new questionnaire. Pain Physician. 2014;17:95-108.

https://doi.org/10.36076/ppj.2014/17/95

PMid:24452650

12. Ferreira-Valente MA, Pais-Ribeiro JL, Jensen MP. Validity of four pain intensity rating scales. Pain. 2011;152:2399-404.

https://doi.org/10.1016/j.pain.2011.07.005

PMid:21856077 

13. La Touche R, Pardo-Montero J, Cuenca-Martínez F, Visscher CM, Paris-Alemany A, López-de-Uralde-Villanueva I. Cross-Cultural Adaptation and Psychometric Properties of the Spanish Version of the Tampa Scale for Kinesiophobia for Temporomandibular Disorders. J Clin Med. 2020;9:2831.

https://doi.org/10.3390/jcm9092831

PMid:32882930 PMCid:PMC7563282

14. García Campayo J, Rodero B, Alda M, Sobradiel N, Montero J, Moreno S. Validación de la versión española de la escala de la catastrofización ante el dolor (Pain Catastrophizing Scale) en la fibromialgia. Med Clin (Barc). 2008;131:487-92.

https://doi.org/10.1157/13127277

PMid:19007576 

15. López-Jornet P, Camacho-Alonso F, López-Tortosa J, Tovar TP, Rodríguez-Gonzales MA. Assessing quality of life in patients with head and neck cancer in Spain by means of EORTC QLQ-C30 and QLQ-H&N35. J Craniomaxillofac Surg. 2012;40:614-20.

https://doi.org/10.1016/j.jcms.2012.01.011

PMid:22425499 

16. Rolke R, Baron R, Maier Ca, Tölle T, Treede R, Beyer A, et al. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values. Pain. 2006;123:231-43.

https://doi.org/10.1016/j.pain.2006.01.041

PMid:16697110 

17. La Touche R, Paris-Alemany A, Gil-Martínez A, Pardo-Montero J, Angulo-Díaz-Parreño S, Fernández-Carnero J. Masticatory sensory-motor changes after an experimental chewing test influenced by pain catastrophizing and neck-pain-related disability in patients with headache attributed to temporomandibular disorders. J Headache Pain. 2015;16:20.

https://doi.org/10.1186/s10194-015-0500-1

PMid:25902781 PMCid:PMC4385233

18. Beltran-Alacreu H, López-de-Uralde-Villanueva I, Paris-Alemany A, Angulo-Díaz-Parreño S, La Touche R. Intra-rater and Inter-rater reliability of mandibular range of motion measures considering a neutral craniocervical position. J Phys Ther Sci. 2014;26:915-20.

https://doi.org/10.1589/jpts.26.915

PMid:25013296 PMCid:PMC4085221

19. Lowery AE, Greenberg MA, Foster SL, Clark K, Casden DR, Loscalzo M, et al. Validation of a needs‐based biopsychosocial distress instrument for cancer patients. Psychooncology. 2012;21:1099-106.

https://doi.org/10.1002/pon.2008

PMid:21830256 

20. Shimizu K, Nakaya N, Saito-Nakaya K, Akechi T, Yamada Y, Fujimori M, et al. Clinical biopsychosocial risk factors for depression in lung cancer patients: a comprehensive analysis using data from the Lung Cancer Database Project. Ann Oncol. 2012;23:1973-9.

https://doi.org/10.1093/annonc/mds061

PMid:22473594 

21. Bilal S, Doss JG, Cella D, Rogers SN. Quality of life associated factors in head and neck cancer patients in a developing country using the FACT-H&N. J Craniomaxillofac Surg. 2015;43:274-80.

https://doi.org/10.1016/j.jcms.2014.11.024

PMid:25555894 

22. Tesic M, Cankovic M, Jevtic M, Stevanovic D. Validation of the oral health impact profile - 14 in patients with head and neck cancer. Med Oral Patol Oral Cir Bucal. 2020;25:e739-44.

https://doi.org/10.4317/medoral.23765

PMid:32388514 PMCid:PMC7648921

23. Pace‐Balzan A, Cawood J, Howell R, Lowe D, Rogers S. The liverpool oral rehabilitation questionnaire: a pilot study. J Oral Rehabil. 2004;31:609-17.

https://doi.org/10.1111/j.1365-2842.2004.01279.x

PMid:15189321 

24. Rogers S, Forgie S, Lowe D, Precious L, Haran S, Tschiesner U. Development of the International Classification of Functioning, Disability and Health as a brief head and neck cancer patient questionnaire. Int J Oral Maxillofac Surg. 2010;39:975-82.

https://doi.org/10.1016/j.ijom.2010.06.006

PMid:20692122 

25. Nazar G, Garmendia ML, Royer M, McDowell JA, Weymuller Jr EA, Yueh B. Spanish validation of the University of Washington Quality of Life questionnaire for head and neck cancer patients. Otolaryngol Head Neck Surg. 2010;143:801-7.

https://doi.org/10.1016/j.otohns.2010.08.008

PMid:21109081 

26. Balaguer M, Percodani J, Woisard V. The Carcinologic Handicap Index (CHI): A disability self-assessment questionnaire for head and neck cancer patients. Eur Ann Otorhinolaryngol Head Neck Dis. 2017;134:399-403.

https://doi.org/10.1016/j.anorl.2017.06.010

PMid:28826665 

27. Rogers SN, Lowe D. An evaluation of the head and neck cancer patient concerns inventory across the Merseyside and Cheshire network. Br J Oral Maxillofac Surg. 2014;52:615-23.

https://doi.org/10.1016/j.bjoms.2014.04.011

PMid:24927654 

28. Simard EP, Torre LA, Jemal A. International trends in head and neck cancer incidence rates: differences by country, sex and anatomic site. Oral Oncol. 2014;50:387-403.

https://doi.org/10.1016/j.oraloncology.2014.01.016

PMid:24530208 

29. Fischer DJ, Villines D, Kim YO, Epstein JB, Wilkie DJ. Anxiety, depression, and pain: differences by primary cancer. Support Care Cancer. 2010;18:801-10.

https://doi.org/10.1007/s00520-009-0712-5

PMid:19685346 PMCid:PMC3682075

30. Rogers SN, Cross B, Talwar C, Lowe D, Humphris G. A single-item screening question for fear of recurrence in head and neck cancer. Eur Arch Otorhinolaryngol. 2016;273:1235-42.

https://doi.org/10.1007/s00405-015-3585-x

PMid:25749490